Wyeth, Alaven Dodge Generic Reglan Suit

By Sindhu Sundar (January 14, 2015, 9:33 PM EST) -- Wyeth LLC and Alaven Pharmaceuticals LLC on Monday dodged a fraud and negligence suit by the mother of a teenager who committed suicide after being treated with a generic version of gastric drug Reglan, when a Mississippi federal judge ruled that the brand-name makers cannot be liable for drugs they did not produce.

U.S. District Judge Glen Davidson granted a summary judgment bid by Wyeth and Alaven, ruling that Mississippi products liability law only imposes liability on defendants who made the products in question. Here, the plaintiff, Diane Truddle, had not shown enough proof that her son, Eric Carmichael, took the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!